Medifast (NYSE:MED) Stock Price Crosses Above 200 Day Moving Average - What's Next?

Key Points

• Medifast's stock price surpassed its 200-day moving average of $13.60, trading as high as $13.85 on Thursday, with a closing price of $13.63.
• The company reported $0.04 EPS for the last quarter, exceeding analysts' estimates of ($0.22) and achieving revenues of $105.56 million compared to expectations of $96.10 million.
• Institutional investors own 95.51% of Medifast's stock, with Deutsche Bank and Two Sigma Investments increasing their stakes significantly over the last quarter.

Medifast Inc (NYSE:MED - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $13.60 and traded as high as $13.85. Medifast shares last traded at $13.63, with a volume of 133,984 shares traded.

Medifast Price Performance

The firm has a market cap of $149.83 million, a P/E ratio of 42.60 and a beta of 0.82. The stock has a 50 day moving average of $13.88 and a 200 day moving average of $13.60.

Medifast (NYSE:MED - Get Free Report) last released its earnings results on Monday, August 4th. The specialty retailer reported $0.04 EPS for the quarter, beating analysts' consensus estimates of ($0.22) by $0.26. The business had revenue of $105.56 million for the quarter, compared to analysts' expectations of $96.10 million. Medifast had a return on equity of 2.00% and a net margin of 0.76%. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. On average, research analysts predict that Medifast Inc will post 0.51 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in MED. Deutsche Bank AG increased its stake in Medifast by 10.4% in the fourth quarter. Deutsche Bank AG now owns 29,553 shares of the specialty retailer's stock valued at $521,000 after acquiring an additional 2,787 shares during the last quarter. Two Sigma Investments LP increased its stake in Medifast by 11.4% in the fourth quarter. Two Sigma Investments LP now owns 232,069 shares of the specialty retailer's stock valued at $4,089,000 after acquiring an additional 23,822 shares during the last quarter. GAMMA Investing LLC boosted its position in Medifast by 3,207.2% during the first quarter. GAMMA Investing LLC now owns 3,208 shares of the specialty retailer's stock valued at $43,000 after buying an additional 3,111 shares during the period. SummerHaven Investment Management LLC boosted its position in Medifast by 2.2% during the first quarter. SummerHaven Investment Management LLC now owns 42,073 shares of the specialty retailer's stock valued at $567,000 after buying an additional 916 shares during the period. Finally, Values First Advisors Inc. boosted its position in Medifast by 3.8% during the first quarter. Values First Advisors Inc. now owns 64,228 shares of the specialty retailer's stock valued at $869,000 after buying an additional 2,340 shares during the period. Institutional investors own 95.51% of the company's stock.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.